SAN DIEGO (dpa-AFX) - Swiss drugmaker Roche (RHHBY.PK) sent an open letter to shareholders of Illumina Inc. (ILMN) urging them to vote the GOLD proxy card for Roche's independent director nominees and other proposals at the 2012 Illumina annual meeting to be held on 18 April 2012.
In late January, Roche commenced a tender offer to acquire all shares of Illumina for $44.50 per share in cash. The offer was raised to $51.00 per share in cash on March 29. But the Illumina board has cited the company's growth prospects in the next generation sequencing market and rebuffed the sweetened offer as grossly inadequate.
Copyright RTT News/dpa-AFX
© 2012 AFX News
